Areta L. Kupchyk

areta-kupchyk-nixon-peabodyAreta Kupchyk is a partner with Nixon Peabody LLP who provides counsel to clients on the U.S. Food and Drug Administration (FDA) regulation of drug, medical device, biotechnology, and biologic products.
Formerly an Associate Chief Counsel for Drugs and Biologics and Assistant General Counsel for Litigation at the FDA, Ms. Kupchyk possesses a nuanced understanding of FDA regulatory procedure that allows her to insightfully navigate clients through all phases of product development, review, and approval, including obtaining approvals with market protections such as three-year market exclusivity for new indications requiring clinical studies, five-year market exclusivity for new chemical entities, and seven-year market exclusivity for orphan drugs.

 

Tall sidebar CTA
Scce workshop
Volkov's book about DOJ featuring a road sign on the cover
Compliance Job Interview Q&A
  • Avi Chiat June 24, 2019
    SEC Obtains Final Judgment Against Defendant in Hedge Fund Fraud Scheme
  • Donald S. LaGuardia, Jr. June 24, 2019
    SEC Charges Founder of Bankrupt Advisory Firm with Fraud
  • Andrew J. Kandelapas June 21, 2019
    Former CEO of Chicago-Area Public Company Pleads Guilty in Market Manipulation Scheme

Stay Connected!

Get CCI's weekly GRC news blast right in your inbox!
SUBSCRIBE
close-link